6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA
Phase of Trial: Phase III
Latest Information Update: 30 Jun 2016
At a glance
- Drugs Flibanserin (Primary)
- Indications Decreased libido; Female sexual dysfunction
- Focus Registrational; Therapeutic Use
- Acronyms DAHLIA
- Sponsors Boehringer Ingelheim
- 11 Dec 2013 Sprout Pharmaceuticals announced in a media release that it had received and appealed the FDA's Complete Response Letter (CRL) for flibanserin for the treatment of HSDD; the CRL was in response to resubmission of data from the Bouquet trials and others.
- 23 Aug 2007 New trial record.